Yukiko Teramoto

Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study

Yasuhiro Nakamura, Ryota Tanaka, Yuri Asami et al. · The Journal of Dermatology · 2016 · 223 citations

Medicine, Dermatology, Oncology +15

Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Kenji Yoshino et al. · Annals of Oncology · 2020 · 140 citations

Medicine, Clinical Sciences, Oncology +17

Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients

Yukiko Teramoto, Ulrike Keim, Anja Gesierich et al. · British Journal of Dermatology · 2017 · 132 citations

Medicine, Dermatology, Oncology +17

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 57 citations · Full text

Medicine, Immunology, Oncology +17

Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019

Yasuhiro Nakamura, Jun Asai, Hiroshi Igaki et al. · The Journal of Dermatology · 2019 · 50 citations · Full text

Medicine, Dermatology, Radiation Oncology +16